The aim of this study was to analyze the current epidemiological situation of measles, its clinical course, and the effectiveness of preventive measures. The study was based on epidemiological surveillance of measles cases registered in the Republic of Uzbekistan during 2020–2024. The clinical course was evaluated using data from 120 patients treated in the measles ward of the 3rd Clinic of the Tashkent Medical Academy. The main symptoms of the disease, distribution by age groups, and the relationship with vaccination coverage were analyzed using statistical methods. According to the results, measles was most frequently observed in children aged 1–5 years (68%). The most common clinical signs were fever (95%), rash (100%), cough (85%), and conjunctivitis (70%). The incidence was significantly lower in regions with high vaccination coverage (p<0.05). These findings indicate that measles still remains a pressing health problem. It has been proven that increasing vaccination coverage can reduce the incidence of the disease.

Measles, epidemiology, clinical symptoms, infectious disease, pediatrics, vaccination, prevention, Uzbekistan.

Moss WJ. Measles. Lancet. 2017;390(10111):2490–2502.

Parums DV. A review of the resurgence of measles, a vaccine‑preventable viral infection. Hum Vaccin Immunother. 2024. (PMC)

Bassetti M. Epidemiology, clinical overview, and potential risk of a new... IDCases. 2024. (Lippincott Journals)

Mathis AD et al. Measles — United States, January 1–March 28, 2024. MMWR Morb Mortal Wkly Rep. 2024. (CDC)

CDC. Measles Update — United States, January 1–April 17, 2025. MMWR Morb Mortal Wkly Rep. 2025. (CDC)

Hewitt GL et al. Measles outbreaks in the United States in 2025. PMC. 2025. (PMC)

van der Staak M et al. Long‑term dynamics of measles virus–specific neutralizing antibodies in children vaccinated before 12 months. Clin Infect Dis. 2025. (Oxford Academic)

Hopkins R. Measles 2025: Looking back and moving forward. ContagionLive. 2025. (ContagionLive)

Mpabalwani E. Global resurgence of measles: turning the tide through a... Int J Infect Dis. 2025. (IJID Online)

Zhao S et al. Comparative analysis of long‑term measles immune... Vaccines (Basel). 2025. (MDPI)

NEJM Review: Measles 2025. New England Journal of Medicine. 2025. (New England Journal of Medicine)

Dattani S, Spooner F. Measles vaccines save millions of lives each year. Our World in Data. 2025. (Our World in Data)

US tipping point for return of endemic measles. Reuters. 2025. (Reuters)

Wired/Stanford study on measles endemic risk. Wired. 2025. (WIRED)

People.com: US measles cases record high since elimination; 2025. (People.com)